Utility of multimodality molecular profiling for pediatric patients with central nervous system tumors.
Rajappa P, Eng KW, Bareja R, Bander ED, Yuan M, Dua A, Bhanu Maachani U, Snuderl M, Pan H, Zhang T, Tosi U, Ivasyk I, Souweidane MM, Elemento O, Sboner A, Greenfield JP, Pisapia DJ.
Rajappa P, et al. Among authors: yuan m.
Neurooncol Adv. 2022 Mar 10;4(1):vdac031. doi: 10.1093/noajnl/vdac031. eCollection 2022 Jan-Dec.
Neurooncol Adv. 2022.
PMID: 35475276
Free PMC article.